George Demetri's Net Worth
$2.31 Million
Who is George Demetri?
George Demetri has an estimated net worth of $2.31 Million. This is based on reported shares across multiple companies, which include Blueprint Medicines Corp, Translate Bio, Inc., and MERRIMACK PHARMACEUTICALS INC.
SEC CIK
George Demetri's CIK is 0001639147
Past Insider Trading and Trends
2020 was George Demetri's most active year for acquiring shares with 4 total transactions. George Demetri's most active month to acquire stocks was the month of May. 2018 was George Demetri's most active year for disposing of shares, totalling 7 transactions. George Demetri's most active month to dispose stocks was the month of August. 2021 saw George Demetri paying a total of $826.60 for 26,760 shares, this is the most they've acquired in one year. In 2018 George Demetri cashed out on 11,742 shares for a total of $1,101,477.18, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Blueprint Medicines Corp (BPMC) Snapshot price: $74.53
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +44.74% | 2.6K |
$70.61 | $241.00 | 8.41K |
Jul 13 - Jun 21
| |||
Form 4
| +63.17% | 2.25K |
—
|
—
| 5.81K |
Jun 2
| |||
Form 4
| -17.55% | -758.00 |
$112.15 | -$85,009.70 | 3.56K |
Scheduled
|
Jan 4
| ||
Form 4
| -28.29% | -1.70K |
$85.00 | -$144,840.00 | 4.32K |
Scheduled
|
Sep 22
| ||
Form 4
| +59.62% | 2.25K |
—
|
—
| 6.02K |
Jun 24
| |||
Form 4
| +53.29% | 1.31K |
—
|
—
| 3.77K |
Jun 19
| |||
Form 4
| -18.75% | -568.00 |
$85.00 | -$48,280.00 | 2.46K |
Scheduled
|
Jan 10
| ||
Form 4
| -36.01% | -1.71K |
$80.59 | -$137,405.95 | 3.03K |
Scheduled
|
Jan 7
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
| -19.35% | -1.14K |
$98.50 | -$111,890.32 | 4.74K |
Scheduled
|
Jun 17
| ||
Form 4
| -8.82% | -568.00 |
$90.00 | -$51,120.00 | 5.87K |
Scheduled
|
Jun 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| -46.03% | -5.49K |
$100.09 | -$549,671.68 | 6.44K |
Scheduled
|
Mar 19
| ||
Form 4
| -34.38% | -6.25K |
$88.29 | -$551,805.50 | 11.93K |
Scheduled
|
Feb 27
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Translate Bio, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MERRIMACK PHARMACEUTICALS INC (MACK) Snapshot price: $13.37
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||